The JAK-STAT pathway at 30: Much learned, much more to do-Reference-Cited by-同舟云学术

The JAK-STAT pathway at 30: Much learned, much more to do

Published:2022-10 Issue:21 Volume:185 Page:3857-3876
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Philips Rachael L.^ORCID,Wang Yuxin,Cheon HyeonJoo,Kanno Yuka,Gadina Massimo,Sartorelli Vittorio,Horvath Curt M.,Darnell James E.,Stark George R.,O’Shea John J.^ORCID

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

National Heart, Lung, and Blood Institute

National Cancer Institute

National Institute of General Medical Sciences

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference168 articles.

1. Analysis of gene expression using high-density and IFN-gamma-specific low-density cDNA arrays;Aberger;Genomics,2001

2. SOCS1 mimetics and antagonists: A complementary approach to positive and negative regulation of immune function;Ahmed;Front. Immunol.,2015

3. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway;Akira;Cell,1994

4. Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer;Alhayyani;Oncogene,2022

5. JAK inhibitor therapy in a child with inherited USP18 deficiency;Alsohime;N. Engl. J. Med.,2020

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK activity regulates mesoderm cell fate by controlling MESP1 expression;European Journal of Cell Biology;2024-12

2. From regulation of cell fate decisions towards patient-specific treatments, insights from mechanistic models of signalling pathways;Current Opinion in Systems Biology;2024-12

3. STATs, promising targets for the treatment of autoimmune and inflammatory diseases;European Journal of Medicinal Chemistry;2024-11

4. The crosstalk between DNA-damage responses and innate immunity;International Immunopharmacology;2024-10

5. Role of tumor-derived exosomes mediated immune cell reprograming in cancer;Gene;2024-10